ABSTRACT- Nuclease-resistant 25 jaM. An N3-methylthymidine-containing phosphorothioate analog, which does not hybridize efficiently in vitro to complementary normal DNA, showed no antiviral activity. A 14-mer phosphorothioate oligodeoxycytidine (S-dC14) synergistically enhanced the antiviral activity of 2',3'-dideoxyadenosine, an anti-HIV nucleoside. Therefore, phosphorothioate analogs of oligodeoxynucleotides could represent a unique class of experimental therapeutic agents against the acquired immunodeficiency syndrome and related diseases. However, their mechanisnm of action is likely to be complex.
shown by Southern blot analysis. However, S-dC28 failed to inhibit gag expression in chronically infected T cells assessed by inmunofluorescent assay at concentrations up to 25 jaM. An N3-methylthymidine-containing phosphorothioate analog, which does not hybridize efficiently in vitro to complementary normal DNA, showed no antiviral activity. A 14-mer phosphorothioate oligodeoxycytidine (S-dC14) synergistically enhanced the antiviral activity of 2',3'-dideoxyadenosine, an anti-HIV nucleoside. Therefore, phosphorothioate analogs of oligodeoxynucleotides could represent a unique class of experimental therapeutic agents against the acquired immunodeficiency syndrome and related diseases. However, their mechanisnm of action is likely to be complex.
Oligodeoxynucleotides (ODNs; Fig. 1 Left), which are complementary to certain gene messages or viral sequences, referred to as "antisense" compounds, have been reported to have inhibitory effects against Rous sarcoma virus (1, 2) and HTLV-III (3) , now called HIV. However, the susceptibility of the phosphodiester linkage in n-ODNs ( Fig. 1 Left, I) to degradation by nucleases (4) would be expected to reduce their potency and in vivo persistence as antiviral agents. M-ODNs analogs ( Fig. 1 Left, II) are resistant to nucleases and, being uncharged, have increased hydrophobicity, which reportedly confers increased cell membrane permeability upon these compounds (5, 6) . M-ODNs have been found to exhibit antiviral activity but may require high concentrations (typically 100-300 uM) to elicit strong antiviral effects (5). S-ODNs, in which one of the nonbridging oxygen atoms in each internucleotide phosphate linkage is replaced by a sulfur atom ( Fig. 1 Left, III), have several properties that make them potentially advantageous antiretroviral analogs. They are stable to cleavage by nucleases (7) and, having the same number of charges as n-ODNs, have good aqueous solubility.
They also exhibit more efficient hybridization with a complementary DNA sequence than the corresponding methylphosphonate analogs (unpublished data). These factors led us to test certain S-ODNs as antiviral agents against HIV.
MATERIALS AND METHODS
Synthesis and Purification of ODNs and Their Methylphosphonate and Phosphorothioate Analogs. The n-ODNs, MODNs, and S-ODNs were synthesized by either the standard procedure or by modification of the reported procedure (8) using an automated synthesizer (Applied Biosystems, Foster City, CA; model 380-B) by the phosphoroamidite method. Purification was performed by reverse-phase high-performance liquid chromatography. The details of synthesis and purification of M-ODNs and S-ODNs will be described elsewhere. The presence of P-S bonds in the phosphorothioates was shown using 31P NMR spectroscopy (8) . N3-methylthymidine was prepared according to a published procedure (9) , then converted to the protected phosphoroamidite form, and incorporated into the oligomer synthesis. (10) (11) (12) (13) . ODN-2 is the "sense" counterpart of ODN-1. ODN-4 is a "random" sequence that has the same base composition as ODN-1, but has <70% homology with any sequence in HTLV-III BH10 clone either as a sense or antisense sequence. The factors of base composition and chain length were evaluated with homooligomers of deoxyadenosine, deoxycytidine, and deoxythymidine in three lengths (5-, 14-, and 28-mer). An N3-methylthymine-containing analog of S-ODN-1 (N-Me-S-ODN-1) was used to assess the role of hybridization in the antiviral effect, since N3-methyl substitution on thymidine is known to significantly reduce duplex stability (14) . In fact, N-Me-S-ODN-1 gave no measurable melting temperature (midpoint of duplex to single-strand transition; tm) with its complementary DNA sequence under physiological conditions (unpublished data).
Cytopathic Effect Inhibition Assay for Assessment of Anti-HIV Activity. We previously reported an in vitro HIV cytopathic effect inhibition assay for assessing anti-HIV activity (15) is N3-methyl-thyniidine-containing antisense ODN, which has methylated thymidine at positions 4 and 9. Random sequence ODN-4 has a same base content as ODN-1 but has <70o homology with any sequence in HTLV-III BH10 genomic sequence as antisense or sense. Homooligomers of deoxycytidine and deoxyadenosine were synthesized with three lengths (5-, 14-, and 28-mer). LTR, long terminal repeat. unnecessary) and then incubated with Polybrene for 45 min. Following the centrifugation, each set of pelleted cells was incubated with HTLV-III for 1 hr [500 virus particles per cell unless otherwise indicated; this dose is :100-1000 times higher than the minimum cytopathic dose in our assay system (16) ]. Complete medium (2 ml of RPMI 1640) supplemented with L-glutamine (4 mM), 2-mercaptoethanol (50 nM), penicillin (50 units/ml), and streptomycin (50 ,g/ml) and containing 15% fetal calf serum and interleukin 2 (IL-2) (15% of conventional IL-2 from Advanced Biotechnologies, Silver Spring, MD, and 20 units of recombinant IL-2 per ml from Amgen Biologicals, Thousand Oaks, CA) was used with various concentrations of oligomers added. The number of viable cells was counted in a hemocytometer using the trypan blue dye-exclusion method on day 7 following exposure to the virus. Each set of data in tables and figures was obtained from simultaneously performed experiments to make a precise comparison among agents tested.
Determination of HIV gag-Encoded Protein Expression. The percentage of the cells expressing p24 gag (group-specific antigen) protein of HIV was determined by indirect immunofluorescence microscopy as described (17) by using anti-HIV p24 murine monoclonal antibody (M26; kindly provided by F. D. Veronese and R. C. Gallo).
Southern Blot Analysis. Target cells (1 x 107 ATH8 cells) were pretreated with or without a 28-mer phosphorothioate oligodeoxycytidine (S-dC28) at various concentrations for 16 hr, treated with Polybrene, exposed to HTLV-IlIB (500 virus particles per cell), resuspended, and cultured in the presence or absence of S-dC28. On days 4 and 7 following exposure to the virus, high molecular weight DNA was extracted, digested with Asp718 (a Kpn I isoschizomer) (Boehringer Mannheim), and subjected to Southern blot analysis hybridized with a labeled insert of molecular clone of the env region of HTLV-III (BH10) containing a 1.3-kilobase (kb) Bgl II fragment.
RESULTS
Antiviral Activity of Phosphorothioate Analogs. Results of the antiviral effect and cytotoxicity of ODNs are presented in Table 1 . The two n-ODNs and one M-ODN tested showed no significant inhibitory effects, whereas all of the S-ODNs exhibited significant inhibition of the cytopathic effect of HIV. Surprisingly, the 14-mer phosphorothioate homooligomer ofdC(S-dC14) was found to be the most potent antiviral compound among those tested in this series of experiments. Since phosphorothioate ODNs that are not antisense sequences appear to be very effective antiviral agents, we tried to clarify the nature of the base composition effect. When comparing the effects of each of the 14-mer phosphorothioates tested at 5 juM, it was found that inhibition of the viral cytopathic effect was approximately linear with respect to the G+C content of the analog (data from Table 1 ). 
and Oligo(dA) Phosphorothioates. Because it is possible that interassay variation may create an inappropriate comparison of antiviral activity among agents, we performed experiments simultaneously to make more precise comparisons.
As illustrated in Fig. 2 Left, the inhibitory effects of S-dC, are greater and more persistent than those of S-dA,, for the 14-mer and 28-mer, whereas 5-mers belonging to both categories fail to significantly inhibit the cytopathic effect of the virus. The order of effectiveness of the homooligomers was deoxycytidine > deoxythymidine 2 deoxyadenosine for the 14-mer (data not shown for deoxythymidine). We then explored the effect of oligomer length in detail. The longer sequences were found to be more effective than the shorter sequences at the same molar concentration of nucleotide unit. For example, in Fig. 2 phosphorylation. It was, therefore, of interest to see if we could observe synergistic antiviral effects when we combined an antiviral oligomer with a dideoxynucleoside. The combination of ddAdo and 14-mer oligodeoxycytidine phosphorothioate gave a marked synergistic enhancement of antiviral activity (Fig. 5) . For example, 2 ,uM ddAdo showed complete protection of target cells against the viral cytopathic effect with 5 ,uM S-dC14, whereas each of the agents alone showed very marginal protective effects in this experiment.
DISCUSSION
Since only phosphorothioate analogs showed anti-HIV activity (Table 1) in our assay, we presume that it is mainly the relative resistance of the phosphorothioate analogs to nucleases that preserves them relative to n-ODNs and allows them to reach and remain at their target site. This was supported in relation to the medium used in our in vitro test system by following the 31P NMR spectra ofthe n-ODN-1 and S-OND-1 compounds as a function oftime. Breakdown ofthe n-ODN was seen from the buildup of the terminal phosphate peak, indicating a half-life of =17 hr under these conditions, 4 . Inhibition of de novo HIV DNA synthesis in ATH8 cells exposed to the virus by the 28-mer of oligodeoxycytidine phosphorothioate. On day 4 (lanes A-E) and day 7 (lanes F-J) following exposure to the virus, high molecular weight DNA was extracted.
Lanes A and F contain DNA from ATH8 cells that were exposed to the virus and not protected by S-dC28. Lanes B and G, C and H, and D and I contain DNA from ATH8 cells pretreated and cultured with 1,5, and 7,M S-dC28, respectively. Lanes E and J contain DNA from ATH8 cells treated with 50 AM 2',3'-dideoxyadenosine (ddAdo), and lane K contains DNA from ATH8 cells that was not exposed to the virus. Sizes are shown in kb. The 2.7-kb env-containing internal Kpn I fragment of the virus genome was detected only in lanes A and F.
whereas the S-analogs exhibited no significant degradation even after a week (within the accuracy of the method, <5%). Similarly, samples of solutions of S-ODNs taken from our in vitro cytopathic assay and incubated in human serum at 37°C showed no degradation after 7 days (data not shown). The inactivity of a methylphosphonate analog (M-ODN-1) in our cytopathic inhibition assay could have been due to its poor with S-dC14. The target cells were pretreated with various concentrations of S-dC14 for 16 hr, pretreated with Polybrene (2 ,ug/ml), exposed to 1000 virus particles per cell for 1 hr, and resuspended in 2 ml of complete medium containing IL-2 with or without various concentrations of ddAdo. On day 13 after exposure to the virus, viable cells were counted by the trypan blue dye-exclusion method. These experiments involved a more potent viral inoculum for a longer duration than in the other experiments reported here.
ability to hybridize strongly to the target sequence (low ti; unpublished data). The potency of anti-HIV activity of S-dC28, one of most potent analogs tested, is almost comparable to that of ddCyd (15) on the basis of molarity (both agents showed complete antiviral activity at 0.5 AM in our assay system); also in terms of therapeutic index (ratio of cytotoxic concentration to effective concentration), S-dC28 generally shows a comparable in vitro index to those of ddCyd and ddAdo (i.e., [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] (15).
Generally it has been assumed that antisense sequences inhibit the expression of various genes by translation arresti.e., that they bind to mRNA and block its translation (18, 19 (Fig. 4) . Therefore, one mechanism for the antiviral effect could depend on blocking viral replication perhaps prior to, or at the stage of, proviral DNA synthesis.
We tested the possibility that the S-ODN analogs may interfere with HIV binding to target cells. The T4 molecule on the cell surface is known to be the main receptor for HIV in T41 cells (20) Fig. 2 Left and Right), suggest that the antiviral activity is mediated by inhibition of HIV proviral DNA synthesis, perhaps brought about, at least in part, by binding of the S-ODNs to a viral nucleotide sequence.
Another mechanism to be considered is induction of interferon production such as that proposed for phosphorothioate analogs of poly-r(I-C) (21) . No induction of 'yinterferon was observed in the supernatant ofthe culture with S-dC14, and 1000 units of recombinant a-or y-interferon added directly to the cultures did not inhibit the cytopathic effect in our assay system. Also since there are no data to support the concept that phosphorothioate internucleotide linkages have a thiol character, and can thus form disulfides, the mechanism of action would likely be different from that proposed for antiviral polynucleotides having thiolated bases such as 5-mercaptocytosine or -uracil (22) .
Phosphatase-resistant 35S-labeled phosphorothioate (endlabeled) (23) S-dC28 was employed to investigate the permeability of target cells. Significant increases of radioactivity in ATH8 and H9 cells were observed within several minutes (unpublished data), as reported for n-ODNs (3), thus sup-S-ODNs also showed substantial inhibition of purified HIV reverse transcriptase activity in the in vitro experiment using a viral DNA (3' orf) inserted in an M13 vector (16) as a template with universal primer (unpublished data) under previously described conditions (24) . Under some conditions, phosphorothioate analogs can serve as competitive inhibitors of template-primer (unpublished data), and this class of compounds appears to have multiple mechanisms of action. The precise mechanism(s), however, including nonsequence specificity of the antiviral activity, direct inhibition of the viral DNA polymerase, or additional translation arrest at high concentration for complementary sequences requires further research at this time. Nevertheless, the anti-HIV effect of these agents is potentially important from a clinical and theoretical point of view.
